150 related articles for article (PubMed ID: 7837727)
21. In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan.
Kohno Y; Ohno H; Miyazaki Y; Higashiyama Y; Yanagihara K; Hirakata Y; Fukushima K; Kohno S
Antimicrob Agents Chemother; 2007 Nov; 51(11):4071-6. PubMed ID: 17709469
[TBL] [Abstract][Full Text] [Related]
22. Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period.
Kobashi Y; Abe M; Mouri K; Obase Y; Kato S; Oka M
J Infect Chemother; 2012 Aug; 18(4):436-43. PubMed ID: 22205543
[TBL] [Abstract][Full Text] [Related]
23. [Diagnosis and treatment of pulmonary nontuberculous mycobacteriosis].
Kurashima A
Kekkaku; 2002 Dec; 77(12):815-21. PubMed ID: 12607341
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and outcomes of clarithromycin treatment for pulmonary MAC disease.
Fujikane T; Fujiuchi S; Yamazaki Y; Sato M; Yamamoto Y; Takeda A; Nishigaki Y; Fujita Y; Shimizu T
Int J Tuberc Lung Dis; 2005 Nov; 9(11):1281-7. PubMed ID: 16333938
[TBL] [Abstract][Full Text] [Related]
25. [In vivo activities of benzoxazinorifamycin KRM-1648, clarithromycin, and levofloxacin, or combination of KRM-1648 with diclofenac sodium against Mycobacterium avium infection induced in mice].
Akaki T; Sato K; Shimizu T; Tomioka H; Kawahara S
Kekkaku; 1997 Aug; 72(8):491-7. PubMed ID: 9293712
[TBL] [Abstract][Full Text] [Related]
26. [Relations between clinical subtypes of Mycobacterium avium pulmonary disease and polyclonal infections detected by IS1245 based restriction fragment length polymorphism analysis].
Kuwabara K; Watanabe Y; Wada K; Tsuchiya T
Kekkaku; 2004 Feb; 79(2):39-46. PubMed ID: 15031998
[TBL] [Abstract][Full Text] [Related]
27. [The clinical study on efficacy of clarithromycin, levofloxacin, and streptomycin for pulmonary Mycobacterium avium-intracellulare complex infection].
Taga S; Ogawa K; Nakagawa T; Tano M
Kekkaku; 2005 Jan; 80(1):1-7. PubMed ID: 15839056
[TBL] [Abstract][Full Text] [Related]
28. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
[TBL] [Abstract][Full Text] [Related]
29. Clarithromycin with minocycline and clofazimine for Mycobacterium avium intracellulare complex lung disease in patients without the acquired immune deficiency syndrome. GETIM. Groupe d'Etude et de Traitement des Infections à Mycobactéries.
Roussel G; Igual J
Int J Tuberc Lung Dis; 1998 Jun; 2(6):462-70. PubMed ID: 9626603
[TBL] [Abstract][Full Text] [Related]
30. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M
J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
[TBL] [Abstract][Full Text] [Related]
31. [Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection].
Dautzenberg B; Saint-Marc T; Durant J; Reynes J; Meyohas MC; Legrand MF; Truffot C; Chauvin JP
Rev Mal Respir; 1994; 11(3):271-6. PubMed ID: 8041990
[TBL] [Abstract][Full Text] [Related]
32. Chronic necrotizing pulmonary aspergillosis as a complication of pulmonary Mycobacterium avium complex disease.
Kobashi Y; Fukuda M; Yoshida K; Miyashita N; Niki Y; Oka M
Respirology; 2006 Nov; 11(6):809-13. PubMed ID: 17052313
[TBL] [Abstract][Full Text] [Related]
33. [New drugs against tuberculosis and nontuberculous mycobacterial infections: a review].
Amitani R; Kuze F
Kekkaku; 1994 Nov; 69(11):711-7. PubMed ID: 7837725
[TBL] [Abstract][Full Text] [Related]
34. Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series.
Davis KK; Kao PN; Jacobs SS; Ruoss SJ
BMC Pulm Med; 2007 Feb; 7():2. PubMed ID: 17319962
[TBL] [Abstract][Full Text] [Related]
35. Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones.
Watanabe M; Hasegawa N; Ishizaka A; Asakura K; Izumi Y; Eguchi K; Kawamura M; Horinouchi H; Kobayashi K
Ann Thorac Surg; 2006 Jun; 81(6):2026-30. PubMed ID: 16731124
[TBL] [Abstract][Full Text] [Related]
36. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
[TBL] [Abstract][Full Text] [Related]
37. The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study.
Kobashi Y; Matsushima T
Respiration; 2007; 74(4):394-400. PubMed ID: 16954651
[TBL] [Abstract][Full Text] [Related]
38. [Clinical features and treatment history of clarithromycin resistance in M. avium-intracellulare complex pulmonary disease patients].
Kuwabara K; Tsuchiya T
Nihon Kokyuki Gakkai Zasshi; 2007 Aug; 45(8):587-92. PubMed ID: 17763685
[TBL] [Abstract][Full Text] [Related]
39. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
40. [Therapeutic effects of benzoxazinorifamycin KRM-1648 administered alone or in combination with glycyrrhizin against Mycobacterium avium complex infection in mice].
Shimizu T; Tomioka H; Sato K; Akaki T; Ogasawara K; Kawahara S
Kekkaku; 1999 Aug; 74(8):617-21. PubMed ID: 10487030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
